Filana Therapeutics, Inc. (FLNA) income statement
FLNANasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.64+0.08 (+14.52%)
Close on Nov 20, 2026Market cap $30.98MP/E –Yield –
Filana Therapeutics, Inc. financial ratios
See a number that looks wrong?